$KNTK

ISQ Global Fund II GP LLC sold $13.3M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 264,074 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $50.49 ($50.04–$51.02, $13.33M total) across 4 trades over 2026-08-03 to 2026-08-07.

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC
Published Aug 8, 2026, 12:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 8, 2026, 12:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KNTK
Neutral
medium confidence
Mentioned
$KNTK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale of 264,074 shares at roughly $50.49 weighted average, totaling about $13.33M, with holdings after the transaction at 1,664,820 shares.

02

Market read

Traders may monitor for follow-on selling and interpret the transaction as a sentiment signal, but there is no new fundamental catalyst in the text.

03

What to watch

The article does not specify whether other insiders or the fund continued selling after 2026-08-07, nor does it provide context on total position size changes beyond the post-transaction share count.

Relevance 7/10Novelty 5/10Timing: filed 2026-08-07, covering sales from 2026-08-03 to 2026-08-07

Background

The filing is an SEC Form 4 insider transaction report for Kinetik Holdings Inc. (KNTK) by ISQ Global Fund II GP LLC, identified as a 10% owner with indirect holdings.

Company-level read

Ticker impact

$KNTKNeutralMedium confidence
Context

ISQ Global Fund II GP LLC, a 10% owner, sold 264,074 KNTK shares in open-market trades for about $13.33M, per Form 4.

Expected impact

Low to modest downside bias for the next few sessions, with limited follow-through unless additional selling or fundamentals emerge.

Evidence & confidence

The filing is a primary-source insider transaction with meaningful size ($13.33M) and no stated 10b5-1 plan, which can increase interpretation risk. However, Form 4 sales often do not imply negative fundamentals, and the article provides no new operating or guidance information.

Market effects

No sector-wide signal; this is a single issuer insider sale with no accompanying industry/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be liquidity-driven portfolio rebalancing by an indirect holder, not a view on KNTK fundamentals, so price impact could fade quickly.

Key entities

  • Kinetik Holdings Inc.

    Subject of the Form 4 insider transaction; shares sold by a 10% owner indirect holder.

  • ISQ Global Fund II GP LLC

    Reporter of the Form 4; 10% owner making an open-market sale of KNTK shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.